Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The single-cell opioid responses in the context of HIV (SCORCH) consortium.

Autor: Ament SA; University of Maryland School of Medicine, Baltimore, MD, USA. sament@som.umaryland.edu., Campbell RR; University of Maryland School of Medicine, Baltimore, MD, USA., Lobo MK; University of Maryland School of Medicine, Baltimore, MD, USA., Receveur JP; University of Maryland School of Medicine, Baltimore, MD, USA., Agrawal K; Yale School of Medicine, New Haven, CT, USA., Borjabad A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Byrareddy SN; University of Nebraska Medical Center, Omaha, NE, USA., Chang L; University of Maryland School of Medicine, Baltimore, MD, USA., Clarke D; Yale School of Medicine, New Haven, CT, USA., Emani P; Yale School of Medicine, New Haven, CT, USA., Gabuzda D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Gaulton KJ; University of California San Diego, La Jolla, CA, USA., Giglio M; University of Maryland School of Medicine, Baltimore, MD, USA., Giorgi FM; University of Bologna, Bologna, Italy., Gok B; Boston University, Boston, MA, USA., Guda C; University of Nebraska Medical Center, Omaha, NE, USA., Hadas E; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Herb BR; University of Maryland School of Medicine, Baltimore, MD, USA., Hu W; Weill Cornell Medicine, New York, NY, USA., Huttner A; Yale School of Medicine, New Haven, CT, USA., Ishmam MR; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jacobs MM; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kelschenbach J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kim DW; Allen Institute for Brain Science, Seattle, WA, USA., Lee C; University of California Irvine, Irvine, CA, USA., Liu S; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Liu X; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Madras BK; McLean Hospital, Harvard Medical School, Belmont, MA, USA., Mahurkar AA; University of Maryland School of Medicine, Baltimore, MD, USA., Mash DC; University of Miami, Miami, FL, USA., Mukamel EA; University of California San Diego, La Jolla, CA, USA., Niu M; University of Nebraska Medical Center, Omaha, NE, USA., O'Connor RM; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Pagan CM; Allen Institute for Brain Science, Seattle, WA, USA., Pang APS; Weill Cornell Medicine, New York, NY, USA., Pillai P; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Repunte-Canonigo V; The Scripps Research Institute, La Jolla, CA, USA., Ruzicka WB; McLean Hospital, Harvard Medical School, Belmont, MA, USA., Stanley J; Yale School of Medicine, New Haven, CT, USA., Tickle T; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tsai SA; National Institute on Drug Abuse, Bethesda, MD, USA., Wang A; University of California San Diego, La Jolla, CA, USA., Wills L; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wilson AM; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wright SN; National Institute on Drug Abuse, Bethesda, MD, USA., Xu S; University of California Irvine, Irvine, CA, USA., Yang J; Yale School of Medicine, New Haven, CT, USA., Zand M; University of California San Diego, La Jolla, CA, USA., Zhang L; Yale School of Medicine, New Haven, CT, USA., Zhang J; University of California Irvine, Irvine, CA, USA., Akbarian S; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Buch S; University of Nebraska Medical Center, Omaha, NE, USA., Cheng CS; University of California San Diego, La Jolla, CA, USA., Corley MJ; Weill Cornell Medicine, New York, NY, USA., Fox HS; University of Nebraska Medical Center, Omaha, NE, USA., Gerstein M; Yale School of Medicine, New Haven, CT, USA., Gummuluru S; Boston University, Boston, MA, USA., Heiman M; Massachusetts Institute of Technology, Cambridge, MA, USA., Ho YC; Yale School of Medicine, New Haven, CT, USA., Kellis M; Massachusetts Institute of Technology, Cambridge, MA, USA., Kenny PJ; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kluger Y; Yale School of Medicine, New Haven, CT, USA., Milner TA; Weill Cornell Medicine, New York, NY, USA., Moore DJ; University of California San Diego, La Jolla, CA, USA., Morgello S; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ndhlovu LC; Weill Cornell Medicine, New York, NY, USA., Rana TM; University of California San Diego, La Jolla, CA, USA., Sanna PP; The Scripps Research Institute, La Jolla, CA, USA., Satterlee JS; National Institute on Drug Abuse, Bethesda, MD, USA., Sestan N; Yale School of Medicine, New Haven, CT, USA., Spector SA; University of California San Diego, La Jolla, CA, USA., Spudich S; Yale School of Medicine, New Haven, CT, USA., Tilgner HU; Weill Cornell Medicine, New York, NY, USA., Volsky DJ; Icahn School of Medicine at Mount Sinai, New York, NY, USA., White OR; University of Maryland School of Medicine, Baltimore, MD, USA., Williams DW; Emory University School of Medicine, Atlanta, GA, USA., Zeng H; Allen Institute for Brain Science, Seattle, WA, USA.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2024 Jun 15. Date of Electronic Publication: 2024 Jun 15.

The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortium.

Autor: Satterlee JS; Division of Neuroscience and Behavior, National Institutes of Health (NIH), 6001 Executive Blvd., Bethesda, MD 20892, USA.; National Institute on Drug Abuse, NIH, 6001 Executive Blvd., Bethesda, MD 20892, USA., Chadwick LH; National Institute on Drug Abuse, NIH, 6001 Executive Blvd., Bethesda, MD 20892, USA., Tyson FL; National Institute of Environmental Health Sciences, NIH, 111 TW Alexander Dr., Durham, NC 27709, USA., McAllister K; National Institute of Environmental Health Sciences, NIH, 111 TW Alexander Dr., Durham, NC 27709, USA., Beaver J; Office of Strategic Coordination, Office of the Director, NIH, 6001 Executive Blvd., Bethesda, MD 20892, USA.; Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 1 Center Dr., Bethesda, MD 20892, USA., Birnbaum L; National Institute of Environmental Health Sciences, NIH, 111 TW Alexander Dr., Durham, NC 27709, USA., Volkow ND; National Institute on Drug Abuse, NIH, 6001 Executive Blvd., Bethesda, MD 20892, USA., Wilder EL; Office of Strategic Coordination, Office of the Director, NIH, 6001 Executive Blvd., Bethesda, MD 20892, USA.; Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 1 Center Dr., Bethesda, MD 20892, USA., Anderson JM; Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 1 Center Dr., Bethesda, MD 20892, USA., Roy AL; Office of Strategic Coordination, Office of the Director, NIH, 6001 Executive Blvd., Bethesda, MD 20892, USA.; Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 1 Center Dr., Bethesda, MD 20892, USA.

Publikováno v: Science advances [Sci Adv] 2019 Jul 10; Vol. 5 (7), pp. eaaw6507. Date of Electronic Publication: 2019 Jul 10 (Print Publication: 2019).